The final phase in acute myeloid leukaemia (AML): A study of cause of death, place of death and type of care during the last week of life
article
The aim of this study was to increase the knowledge of the final phase in acute myeloid leukaemia (AML), a period which entails many complex medical and psychosocial decisions. Data on cause and place of death were gathered through a retrospective review of medical and nursing records of 106 patients with AML who had died during 1995-1997. We focused on the actual phase of the disease and to what extent the patients were prescribed palliative care. With increased knowledge of the dying process in AML there are options to discuss which approach would be the most preferred final phase for an AML patient. Copyright © 2001 Elsevier Science Ltd.
Topics
Acute leukaemiaCost-effectivenessElderlyIntensive treatmentPalliative carePalliative medicineQuality of lifeantibiotic agentantifungal agentcytostatic agentacute granulocytic leukemiaaplasiabone marrow transplantationbrain hemorrhagecancer stagingcause of deathcost effectiveness analysisdeath certificatedecision makingdrug usedyingfemalehealth careheart failurehemodialysishumaninfectionlung diseasemajor clinical studymedical recordmultiple organ failurepainpalliative therapyparenteral nutritionpneumoniasepticemiastrokeSwedenAcute DiseaseAdultAgedAged, 80 and overAttitude to DeathBone Marrow TransplantationCause of DeathDeathFemaleHumansLeukemia, MyeloidMaleMiddle AgedPalliative CareRetrospective StudiesTerminal Care
TNO Identifier
280358
ISSN
01452126
Source
Leukemia Research, 25(8), pp. 673-680.
Pages
673-680
Files
To receive the publication files, please send an e-mail request to TNO Repository.